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Abstract
Background: The tuberous sclerosis complex (TSC) is caused by defects in one of two tumor
suppressor genes, TSC-1 or TSC-2. TSC-2 gene encodes tuberin, a protein involved in the
pathogenesis of kidney tumors, both angiomyolipomas and renal cell carcinomas. Loss of
heterozygosity at the 8-oxoG-DNA glycosylase (OGG1) allele is found in human kidney clear cell
carcinoma identifying loss of OGG1 function as a possible contributor to tumorigenesis in the
kidney. Tuberin regulates OGG1 through the transcription factor NF-YA in cultured cells. The
purpose of this study is to determine the effect of tuberin-deficiency on OGG1 protein and mRNA
levels as well as on 8-oxodG levels in kidney tumors from patients with TSC. In addition we
evaluated the phophorylation level of downstream targets of mTOR, phospho-S70K, in kidney
tumor tissue from TSC patients.
Results: Kidney angiomyolipoma tissue from TSC patients expresses significant levels of phopho-
tuberin and low levels of tuberin compared to control kidney tissue. The increase in tuberin
phosphorylation and the decrease tuberin expression are associated with decrease in OGG1
protein and mRNA levels in tumor samples compared to normal kidney samples. The decrease
OGG1 expression is also associated with significant decrease in the transcription factor, NF-YA,
expression in tumor samples compared to normal tissues. In addition, the levels of 8-oxodG are 4-
fold higher in tumors compared to control samples. The significant increase of phospho-tuberin
expression is associated with increase phosphorylation of S6K in tumor samples compared to
controls. Cyclin D1 expression is also 3-fold higher in increase in the tumor tissues compared to
normal kidney tissues.
Conclusion: These data indicate that tuberin deficiency in angiomyolipoma enhances mTOR
activation by phosphorylation of S6K and downregulation of protein and mRNA expression of
OGG1 resulted in accumulation of oxidized DNA in patients with TSC. These data suggest that
tuberin and OGG1 are important proteins in the pathogenesis of angiomyolipoma in TSC patients.
Background
Tuberous sclerosis complex (TSC) is an autosomal domi-
nant genetic disorder associated with tumors in many
organs, particularly angiomyolipoma in the kidneys and
renal cell carcinoma (RCC). TSC affects about 1 million
individuals worldwide, with an estimated prevalence of
up to 1 in 6,000 newborns [1]. Loss of heterozygosity
(LOH) at the TSC1 or TSC2 loci has been detected in TSC-
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associated hamartomas and renal cell carcinoma (RCC) as
well as in sporadic tumors of non-TSC patients [2]. Multi-
centric angiomyolipomas are much more common in
patients with TSC than RCCs, but may nonetheless have
similar underlying genetic basis at early steps in their gen-
esis and/or progression, specifically in the setting of
tuberin deficiency. Renal angiomyolipomas (ALMs) asso-
ciated with TSC tend to be larger, bilateral, multifocal and
present at a younger age compared with sporadic forms
[2]. ALMs are generally benign tumors, which are com-
posed of smooth muscle, fat, and blood vessels [2]. Kid-
ney cancer development is rare in TSC, occurring in only
2–3% of all patients [3-5]. The TSC2  gene product
(tuberin) is a tumor suppressor protein whose absence or
inactivation is associated with several defects such as
abnormal cellular migration, proliferation, and differenti-
ation [6,7]. Tuberin expression was initially induced fol-
lowing acute renal injury, suggesting that the TSC2 gene
may function as an acute-phase response gene, limiting
the proliferative response after injury [8]. Tuberin is a tar-
get of both serine/threonine and tyrosine kinases [9,10].
Most recently, tuberin has been shown to be a target for
phosphorylation by several kinases including Akt [11].
Akt directly phosphorylates and inactivates TSC2 on Ser
924, Thr 1462 and Thr 1518. These phosphorylations by
Akt disrupt the TSC1-TSC2 complex and disturb the sub-
cellular localization of TSC1 and TSC2 [11].
Oxidative DNA damage has been implicated in carcino-
genesis, ageing and several age-related degenerative dis-
eases [12,13]. 8-Oxo-deoxyguanine (8-oxo-dG) is a
quantitatively major form of oxidative DNA damage
[11,12], inducing mainly G to T and A to C substitutions
[13]. 8-Oxo-dG in DNA is repaired primarily via the DNA
base excision repair pathway. The gene coding for the
DNA repair enzyme that recognizes and excises 8-oxo-dG
is 8-oxoG-DNA glycosylase (OGG1) [14]. Deficiency in
DNA repair enzyme OGG1 has important functional con-
sequences, compromising the ability of cells to repair
DNA [14,15]. OGG1 is a functional, but not structural,
analogue of the bacterial Fpg protein. OGG1 deficiency in
yeast, as well as Fpg deficiency in bacteria, results in a
spontaneous mutator phenotype [16]. The steady-state
levels of 8-oxoG, which reflect the balance between its
continuous generation and removal, are significantly
higher in livers of OGG1-/- mice compared to wild-type
animals [17]. Increased susceptibility to mutagens and
impaired DNA repair can contribute to the genomic insta-
bility and in consequence to cancer. The OGG1 gene is
somatically mutated in some cancer cells and is highly
polymorphic among humans [18]. Loss of heterozygosity
at the OGG1  allele, located on chromosome 3p25, is
found in 85% of 99 human kidney clear cell carcinoma
samples, identifying loss of OGG1 function as a possible
consequence of multistep carcinogenesis in the kidney
[19]. A nuclear factor-YA (NF-YA) has been identified as a
transcription factor that binds to a consensus sequence in
the OGG1 promoter [20]. NF-Y is a ubiquitous transcrip-
tion factor that specifically recognizes a CCAAT box motif
and regulates hOGG1 expression as well as genes that reg-
ulate development and cell cycle [20].
The constitutive expression of OGG1 in heterozygous
Eker rat (TSC2+/-) kidneys is lower than in wild-type rats
[21,22] suggesting that these proteins may be functionally
linked. Downregulation of tuberin in human renal epithe-
lial cells causes in a marked decrease in the abundance of
OGG1 [23]. Mouse embryonic fibroblasts deficient in
tuberin (TSC2-/- and TSC2+/-) also express very low levels
of OGG1 mRNA and protein and undetectable OGG1
activity accompanied by accumulation of 8-oxodG [23].
The present study was conducted to investigate the effect
of tuberin deficiency on phosphorylation of S6Kinase
(downstream targets of mTOR) and on OGG1 expression
and 8-oxodG levels in kidney tumors from TSC patients.
Results
Tuberin phosphorylation is increased and is associated 
with decreased tuberin and OGG1 expression in kidney 
angiomyolipoma tissue
To determine the relevance of our findings in cell culture
[23] and rodents [21,22] to humans, phopho-tuberin,
total tuberin and OGG1 expression was assessed in tissue
homogenates of control kidney tissue and kidney tumors
from patients with tuberous sclerosis. There is increase in
Thr 1462 phospho-tuberin in the tumor tissue compared
to control kidney tissue (Figure 1). The increase tuberin
phophorylation is associated with a decrease in tuberin
levels (Figure 1). In addition decrease tuberin expression
is associated with significant decrease in the mRNA and
protein levels of OGG1 in tumor tissue compared to con-
trol tissue (Figure 2A and Figure 2B).
Downregulation of OGG1 mRNA is associated with 
decreased NF-YA expression in kidney angiomyolipoma 
tissue
The decrease in OGG1 mRNA in kidney tumor samples
suggests that decreased transcription is one potential
mechanism responsible for downregulation of OGG1
protein. NF-YA is a transcription factor that regulates
expression of OGG1. Our recent published data show that
deficiency of tuberin in null and heterozygous mouse
embryonic fibroblast cells is associated with decreased in
NF-YA expression [23]. Protein expression of NF-YA in
normal and tumor kidney samples was analyzed by west-
ern blot. NFYA expression is significantly decreased in
most tumor kidney samples compared to control kidney
samples (Figure 3).Molecular Cancer 2009, 8:13 http://www.molecular-cancer.com/content/8/1/13
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Accumulation of 8-OxodG in kidney angiomyolipoma 
tissue
Tuberin deficiency in Tsc2-null mouse embryonic fibrob-
last cells and in kidney Eker rat results in the accumula-
tion of significant amounts of 8-oxodG [22,23]. To
determine if the decrease in OGG1 is associated with 8-
oxodG accumulation in angiomyolipomas, we quantified
8-oxodG by HPLC in control and tumor kidney samples.
The amount of 8-oxodG in DNA extracted from tumor tis-
sue is 4-fold higher in tumors than in control tissue (Fig-
ure 4).
Increased phosphorylation of tuberin and decreased total tuberin in kidney tumors Figure 1
Increased phosphorylation of tuberin and decreased total tuberin in kidney tumors. Immunoblot analysis of phos-
pho-tuberin (Thr 1462) and tuberin protein expression in normal kidney samples and tumor kidney from patients with tuber-
ous sclerosis. Increased tuberin phosphorylation is associated with decreased total tuberin expression in tumor tissue 
compared to normal tissue. Tubulin was used as loading control. Histograms represent means ± SE normal kidney samples and 
kidney tumors from patients with tuberous sclerosis. Significant difference between control and tumor groups is indicated by 
**P < 0.01.
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Activation of mTOR in kidney angiomyolipoma tissue
To determine if tuberin phosphorylation activates mTOR
in tumor kidney tissue, phospho S6k expression was
measured in kidney tissue homogenates of normal and
tumor tissue from patients with TSC by western blot.
Phosphorylation of S6K on Thr389  is significantly
increased in tumor tissues compared to normal samples
(Figure 5A). Immunostaining of phosp-S6K is signifi-
cantly increased in tumor kidney tissue compared to nor-
mal kidney confirming the increase in mTOR activity
(Figure 5B).
Tuberin deficiency is associated with increased cyclin D1 
expression in kidney angiomyolipoma tissue
To determine the association between tuberin and cyclin
D1, kidney tissue of control and tumor samples were ana-
lyzed by western blot. Cyclin D1 expression is signifi-
cantly increased up to 3-fold in tumor tissues compared to
control tissue indicating that tuberin is upstream of cyclin
D1 (Figure 6).
Discussion
This study is the first report to demonstrate that deficiency
of tuberin in patients with tuberous sclerosis is associated
with significant decrease of OGG1 and accumulation of 8-
oxodG in angiomyolipomas suggesting that both proteins
may play a major role in development of this kidney
tumor. Deficiency and/or enhanced phosphorylation of
tuberin on threonine 1462 results in its inactivation
[19,10]. Our data demonstrate that tuberin phosphoryla-
tion on Thr1462 residue in angiomyolipomas tissue is asso-
ciated with deficiency of total protein. Phosphorylation of
tuberin at this site affects its function through at least two
mechanisms: first, phosphorylation decreases the activity
Tuberin deficiency is associated with decreased protein and mRNA of OGG1 expression in kidney tumors Figure 2
Tuberin deficiency is associated with decreased protein and mRNA of OGG1 expression in kidney tumors. (A) 
Immunoblot analysis of OGG1 protein expression in normal kidney and kidney tumor from patients with tuberous sclerosis. 
Decreased OGG1 is associated with decreased tuberin expression in tumor tissue compared to normal tissue. Tubulin was 
used as loading control. (B) RNA was extracted from kidney or tumor tissue and its integrity tested by formaldehyde/agarose 
gel electrophoresis. RTPCR was performed using one μg RNA from each sample to synthesize first and second strand DNA. 
PCR products were analyzed on ethidium bromide stained gel. Band intensity was quantified for each sample on an image ana-
lyzer and the ratio of OGG1 to actin was calculated. Histograms represent means ± SE normal kidney samples and kidney 
tumors from patients with tuberous sclerosis. Significant difference between control and tumor groups is indicated by **P < 
0.01.
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of tuberin; second, phosphorylation destabilizes tuberin
by disrupting the complex formation between hamartin
and tuberin resulting in ubiquitination of free tuberin and
its degradation by the proteosome [11]. Phosphorylation
of tuberin by Akt also reduces the stability of tuberin and
thereby releases its inhibitory function on p70S6K signal-
ing [11].
The generation of oxidative DNA damage is counteracted
in all species by specific repair mechanisms [15]. OGG1 is
one of the major enzymes involved in the repair of 8-
oxodG adducts in DNA and is highly expressed in kidney
tissue. Loss of heterozygosity at the OGG1  allele was
found in human kidney clear cell carcinoma, identifying
loss of OGG1 function as a possible consequence of mul-
Downregulation of OGG1 mRNA is associated with decreased NF-YA protein expression in kidney tumors Figure 3
Downregulation of OGG1 mRNA is associated with decreased NF-YA protein expression in kidney tumors. 
Immunoblot analysis of NF-YA expression in normal kidney and kidney tumor from patients with tuberous sclerosis. 
Decreased OGG1 is associated with decreased NF-YA expression in tumor tissue compared to normal tissue. Tubulin was 
used as loading control. Histograms represent means ± SE normal kidney samples and tumors kidney from patients with tuber-
ous sclerosis. Significant difference between control and tumor groups is indicated by **P < 0.01.
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tistep carcinogenesis in the kidney [19]. We have previ-
ously shown that the constitutive expression of OGG1 in
TSC2 heterozygous Eker rat (TSC2+/-) kidneys is lower
than in wild-type rats [21]. We now find that decrease in
tuberin protein expression in angiomyolipomas tissues is
associated with a decrease in protein and mRNA expres-
sion of OGG1. Therefore, tuberin deficiency, through its
phosphorylation is upstream of OGG1. The decrease in
OGG1 expression in TSC-2+/- rats has important func-
tional consequences, compromising the ability of these
animals to respond to oxidative stress [21]. The decrease
in OGG1 mRNA in angiomyolipoma tissue suggests that
decreased transcription is one potential mechanism
responsible for downregulation of OGG1 protein. We
have recently shown that suppression of renal OGG1 in
tuberin deficient cells is mediated at least in part through
the transcription factor, NF-YA, the major transcription
factor that regulates the OGG1 gene expression [23]. In
this study, NF-YA expression is decreased in angiomyol-
ipoma tissue compared to control tissue suggesting that
the decrease in OGG1 protein is due to decreased tran-
scription.
The base excision pathway initiated by OGG1 represents
the main defense against the mutagenic effects of 8-
oxodG. Dysregulation of human DNA repair gene OGG1
is associated with an increased cancer risk. 8-OxodG
induces mutation via misincorporation of DNA bases
present in the unrepaired DNA adducts, or by slippage of
DNA polymerase during replicative bypass. In this study,
we demonstrate that 8-OxodG accumulates in angiomyol-
ipomas tissue compared to normal tissue suggesting the
deficiency of DNA repair OGG1. However our new pub-
lished data show that loss of OGG1 expression in kidney
tumor tissue from Eker rat resulted in the accumulation of
significant amounts of 8-oxodG (unrepaired DNA
lesions), suggesting that loss of tuberin is biologically rel-
evant in affecting OGG1 [22]. We recently showed also
that mouse embryonic fibroblasts deficient in tuberin
(Tsc2-/- and Tsc2+/-) had markedly decreased OGG1 mRNA
and protein expression, as well as undetectable OGG1
activity accompanied by accumulation of 8-oxodG. [23].
In addition downregulation of tuberin in human renal
epithelial cells using siRNA resulted in a marked decrease
in the abundance of OGG1 [23]. Mice lacking a functional
OGG1 protein accumulate abnormal levels of 8-oxodG in
their genome and display a moderately elevated sponta-
neous mutation rate in nonproliferative tissues. There-
fore, the antimutator function of OGG1 protein portrays
OGG1 as a strong susceptibility candidate gene for tumors
including angiomyolipoma.
The mammalian target of rapamycin (mTOR) serves a crit-
ical role in regulating the translational machinery that
affects growth, proliferation, and differentiation, all of
which are abnormally manifested in TSC lesions. The
importance of mTOR pathway in human pathology is
reflected in the overexpression of p70S6K in a subset of
cancer and its correlation with a poor prognosis [24]. Acti-
vation of S6 Kinase and its target S6 ribosomal protein
(S6) was demonstrated in cells lacking TSC2 expression
[24]. Recent studies have shown that activation of mTOR
in lymphangioleiomyomatosis-associated angiomyolipo-
mas through phosphorylation of S6 protein at Ser235/
236 [25]. Our data show that phosphorylation of S6
Kinase at Thr389 was significantly higher in angiomyolipo-
mas tissues compared to control samples indicating the
increase of mTOR activity in tumor tissues.
Increased in 8-oxodG levels in kidney tumors Figure 4
Increased in 8-oxodG levels in kidney tumors. DNA 
was extracted from normal kidney and kidney tumor from 
patients with tuberous sclerosis. Detection of dG and 8-
oxodG was performed by HPLC-EC analysis. Authentic 
standards of 8-oxodG and dG were analyzed simultaneously. 
Standard curves for dG and 8-oxodG were prepared and 
quantitated by linear regression analyses Histograms repre-
sent means ± SE normal kidney samples and kidney tumors 
from patients with tuberous sclerosis. Significant difference 
between control and tumor groups is indicated by **P < 0.01.
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Renal cortical tumors from the Eker rat heterozygous for
TSC express elevated cyclin D1 compared with unaffected
kidney tissue [26]. In addition cortical tubers microdis-
sected from TSC patients showed elevated cyclin D1
mRNA expression in giant cells [27]. Tumor cells showed
overexpression of cyclin D1 but lacked the loss of hetero-
zygosity of the TSC1 and TSC2 genes. The result suggests
that the overexpression of cyclin D1 may play an impor-
tant role in the tumorigenesis [28]. Mouse embryonic
fibroblast cells with low copy of TSC2 gene express 4-fold
higher cyclin D1 compared to wild type cells (data not
shown). Cyclin D1 protein expression is 4-fold higher in
angiomyolipomas kidney tissue of patients with TSC
compared to control samples suggesting that partial loss
of tuberin is sufficient to upregulate cyclin D1. In accord-
ance with our observation, cortical tubers microdissected
from TSC patients show elevated cyclin D1 mRNA expres-
sion in the malignant cells [29]. Accumulation of cyclin
D1 together with cyclin-dependent kinases may enhance
cell proliferation in tumor cells tissue and may promote
cells transition from G0/G1 to S phase.
Conclusion
Our data show that the increase in tuberin phosphoryla-
tion and the deficiency in tuberin expression are associ-
ated with decreased protein and mRNA expression of
OGG1 in angiomyolipomas kidney tissue from TSC
patients. Decrease OGG1 results in the accumulation of 8-
oxodG in kidney tumors, suggesting that tuberin plays a
significant role in protecting the cells from oxidative DNA
damage. Mismatched DNA base lesions, a form of
genomic instability that if left unrepaired promotes addi-
tional genetic alterations leading kidney tumor pheno-
type. Increased phosphoylation of S6Kinase at Thr389 in
tumor kidney tissues indicated the increase in mTOR
activity in tumor tissue. In addition, increase cyclin D1
expression in tumor samples suggested that partial loss of
tuberin is sufficient to upregulate cyclin D1 that may
enhance cell proliferation in tumor cells tissue.
Increased phosphoryaltion of S6K in kidney tumors Figure 5
Increased phosphoryaltion of S6K in kidney tumors. (A) Immunoblot and (B) immunostaining analysis of phopho-S6K 
(Thr-389) and total S6K in normal kidney samples and kidney tumor from patients with tuberous sclerosis. Phosphorylation of 
S6K was significantly higher in tumor kidney tissue compared to normal kidney confirming the increase of mTOR activity. 
Tubulin was used as loading control. Histograms represent means ± SE normal kidney samples and kidney tumors from 
patients with tuberous sclerosis. Significant difference between control and tumor groups is indicated by **P < 0.01.Molecular Cancer 2009, 8:13 http://www.molecular-cancer.com/content/8/1/13
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Materials and methods
Kidney tissues
Kidney angiomyolipoma tissue from 20 TSC patients with
renal angiomyolipoma and 18 unrelated healthy people
were obtained from the Brain and Tissue Bank for Devel-
opment Disorders (University of Maryland, Baltimore,
Maryland, USA) and San Antonio Cancer Institute Core,
San Antonio, TX. The study has been approved by the
Institutional Review Board of The University of Texas
Health Science Center at San Antonio, TX.
Protein extraction and immunoblot analysis
Kidney homogenates were prepared using lysis buffer (1×
PBS, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS)
containing the protease inhibitors phenylmethylsulfonyl
fluoride (10 mg/ml), leupeptin (10 mg/ml), and apro-
tinin (20 mg/ml). Kidney homogenates were centrifuged
at 14,000 g for 30 min at 4°C. Protein concentration was
determined with the Bradford assay [30] using bovine
serum albumin as a standard. Protein (100 μg) was sub-
jected to SDS-polyacrylamide gel electrophoresis. Proteins
were transferred to polyvinylidene difluoride (PVDF)
membrane at a constant voltage of 200 V for 1–1.5 h.
PVDF membranes were blocked in 5% nonfat dried milk
in TBS-0.1% Tween buffer [25 mM Tris HCl, 0.2 mM
NaCl, 0.1% Tween 20 (vol/vol), pH 7.6] (TBS-T) for 1 h.
Membranes were incubated with the respective primary
antibodies overnight at 4°C. Rabbit polyclonal antibody
raised against human OGG1 protein was generously pro-
vided by Dr. S. Mitra (University of Texas Medical Branch
at Galveston, Texas). Phosho-tuberin, tuberin, phospho
S6K, S6K were purchased from Cell Signaling Technology
(Danvers, MA). Rabbit anti-NF-YA and cyclin D1 antibod-
ies were purchased from Santa Cruz Biotechnology. All
primary antibodies were prepared at 1:1,000 dilutions in
TBST. Membranes were washed 3× with TBST and then
incubated with an appropriate horseradish peroxidase-
conjugated secondary antibody for 1 h at room tempera-
ture. An enhanced chemiluminescence kit (Amersham)
was used to identify protein expression. Membranes were
stripped with 0.2 M NaOH for 10 min each, blocked with
5% milk for 1 h, and then incubated with the respective
primary and secondary antibodies, as described earlier.
Expression of each protein was quantified by densitome-
try using National Institutes of Health Image 1.62 soft-
ware.
mRNA analysis by RT-PCR analysis
RNA was extracted from kidney tissue of control and
tumors samples using RNeasy Mini kit (Qiagen, Valencia,
CA). RNA was quantitated by spectrophotometery at 260
nm, and its integrity tested by formaldehyde/agarose gel
electrophoresis. First strand synthesis of cDNA was carried
in 20 μl total reaction volume as follows: 1 μl oligo [23]12–
18, 2 μg total RNA, 1 μl of 10 mM dNTP mix (10 mM each
dATP, dGTP, dCTP and dTTP) and 12 μl distilled water.
The mixture was heated at 65°C for 5 min and then
quickly chilled on ice. The contents of the tube were col-
lected by brief centrifugation then 4 μl 5× first-Strand
buffer, 2 μl 0.1 M DTT and 1 μl RNaseOUT Recombinant
Tuberin deficiency is associated with increased cyclin D1 expression in kidney tumors Figure 6
Tuberin deficiency is associated with increased cyclin D1 expression in kidney tumors. Immunoblot analysis of cyc-
lin D1 in normal kidney samples and tumor from patients with tuberous sclerosis. Cyclin D1 was significantly higher in tumor 
kidney tissue compared to normal kidney. Tubulin was used as loading control. Histograms represent means ± SE normal kid-
ney samples and kidney tumors from patients with tuberous sclerosis. Significant difference between control and tumor groups 
is indicated by **P < 0.01.
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Ribonuclease Inhibitor (40 units/μl). The mixture was
incubated at 42°C for 2 min and then 1 μl of SUPER-
SCRIPT II (200 U) was added and mixed by pipetting. The
reaction mixture was incubated for 50 min at 42°C and
then was inactivated by heating at 94°C for 2 min. PCR
reaction was carried out in a final volume of 50 μl as fol-
low: 5 μl 10 × PCR buffer, 1.5 μl 50 mM MgCl2, 1 μl 10
mM dNTP, 0.4 μl Taq DNA polymerase (5 U/μl), 2 μl
cDNA (from first-strand reaction) 1 μl each of OGG1
upstream/reverse primers (5'AACATTGCTCGCATCACT-
GGC/5'GATGTCCACAGGCACAGCCTG) or GADPH
upstream/reverse primers (5'ACCACAGTCCAT-
GCCATCA/5'TCCACCACCCTGTTGCTGTA) and 38.1 μl
autoclaved distilled water. The amplification for OGG1
and GADPH was carried out using a thermocycler (Biom-
etra) programmed for 25 cycles consisting of 95°C (5
min), 95°C (1 min), 52°C (50 sec), 72°C (1 min) and
72°C (10 min) and yielded 356 and 495 bp, respectively
of amplified products. The amplified PCR products were
separated on 2% agarose gels. PCR products were ana-
lyzed on ethidium bromide stained gel. The yield was
integrated for each sample on image analyzer and the
ratio of OGG1 to GAPDH then calculated.
8-OxodG assay
DNA was isolated from the kidney tissue and detection of
dG and 8-oxodG was performed on DNA hydrolyzed with
nuclease P1 and alkaline phosphatase as previously
described and validated [21]. Aliquots (90 μl) of DNA
hydrolysates were injected onto a Partisil 5- m ODS-3
reverse-phase analytical column for HPLC analysis with
the eluate monitored with a UV photodiode array (Shi-
madzo, SPD M10A) and electrochemical (EC) detectors
(ESA Coul Array). Authentic standards of 8-oxodG and dG
were analyzed along with every batch of samples. Salmon
sperm DNA (5–50 μg) was used as a positive control for
DNA digestion reactions. Standard curves for dG and 8-
oxodG were prepared and quantitation was performed by
linear regression analyses. Data were expressed as pico-
moles of 8-oxodG/dG × 10-5 in 90 μl of DNA hydrolysate.
Immunostaining of phospho-S6k
Phospho-S6K expression was also assessed by immun-
ofluorescence histochemistry as previously described
[22]. Acetone-fixed frozen kidney sections (4 μm) were
incubated with nonimmune donkey IgG to block nonspe-
cific binding, then incubated with rabbit anti- Phospho-
S6K antibody followed by fluorescene isothiocyanates
(FITC) FITC-labeled donkey anti-rabbit IgG (Chemicon
International, Inc., Temecula, CA, USA) as secondary anti-
bodies for signal detection. All incubations of primary
and secondary antibodies were for 30 minutes with three
washes with phosphate-buffered saline (PBS) containing
0.1% bovine serum albumin (BSA), 5 minutes each
between steps. Controls consisted of PBS/BSA in place of
primary antibody followed by detection procedures as
outlined above. Kidney sections were viewed and photo-
graphed using an Olympus Research microscope
equipped for epifluorescence with excitation and band
pass filters. FITC green signals for phospho-S6k was
detected using a filter with excitation at 535 nm.
Statistics
Data are presented as mean ± standard error. Statistical
differences were determined using ANOVA followed by
Student Dunnett's (Exp. vs. Control) test using 1 trial
analysis. P-values less than 0.05 and 0.01 were considered
statistically significant.
Abbreviations
TSC2: tuberous sclerosis complex-2; 8-oxodG: 8-oxodeox-
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